Grail Inc.

03/01/2026 | Press release | Archived content

Circulating tumor DNA (ctDNA) analysis from the prospective pT0 study of systematic endoscopic evaluation (SEE) in patients undergoing radical cystectomy (RC) for bladder cancer

Grail Inc. published this content on March 01, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 19, 2026 at 07:41 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]